Tuberculous meningoencephalitis concurrent with autoimmune glial fibrillary acidic protein astrocytopathy: a case report - Report - MDSpire

Concurrent Tuberculous Meningoencephalitis and Autoimmune GFAP Astrocytopathy: A Case Study

  • By

  • Yuan Deng

  • Zeyan Bao

  • SiDian Zhuang

  • Ting Wu

  • ShuiSheng Zhong

  • July 20, 2026

Share

Clinical Report: Concurrent Tuberculous Meningoencephalitis and Autoimmune GFAP Astrocytopathy

Background

Tuberculous meningoencephalitis is a severe CNS infection caused by Mycobacterium tuberculosis, often leading to high mortality and disability if untreated. Autoimmune GFAP astrocytopathy is an inflammatory condition characterized by the presence of GFAP antibodies, complicating the diagnosis of CNS disorders. The overlap of these two conditions can lead to misdiagnosis and challenges in management.

Data Highlights

The patient presented with fever, cognitive slowing, and limb weakness. CSF analysis revealed pleocytosis, increased protein, decreased glucose, and decreased chloride levels. MRI showed multiple parenchymal signal abnormalities and leptomeningeal enhancement.

Key Findings

  • Concurrent tuberculous meningoencephalitis and GFAP astrocytopathy is a rare overlap syndrome.
  • CSF analysis showed pleocytosis and abnormal biochemical markers indicative of both conditions.
  • Positive GeneXpert MTB/RIF confirmed the diagnosis of tuberculous meningoencephalitis.
  • GFAP antibodies were detected in both serum and CSF.
  • Clinical improvement was noted after treatment with antitubercular drugs and corticosteroids.
  • Imaging studies demonstrated paradoxical worsening of lesions after steroid tapering.

Clinical Implications

Clinicians should consider the possibility of concurrent tuberculous meningoencephalitis and GFAP astrocytopathy in patients presenting with overlapping symptoms. Careful monitoring of treatment response and imaging findings is essential to manage potential paradoxical reactions effectively.

Conclusion

This case underscores the complexity of diagnosing and treating overlapping CNS conditions, emphasizing the importance of a comprehensive approach to patient management.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Autoimmune GFAP astrocytopathy with eosinophils on cerebrospinal fluid cytology and isolated spinal cord lesions on MRI: a case report
  2. Acta Neuropathologica, 2023 -- Recent Advances in Understanding the Neuropathology and Mechanisms of Autoimmune GFAP Meningoencephalomyelitis
  3. conexiant, 2023 -- Steroid Pulse Therapy Benefits GFAP Astrocytopathy
  4. WHO consolidated guidelines on tuberculosis, 2025 -- Module 4: treatment and care
  5. New England Journal of Medicine, 2025 -- Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis
  6. Frontiers in Immunology — Triple antibody-associated autoimmune encephalitis overlap: a case report of co-existing MOG-IgG, anti-NMDAR, and anti-mGluR5 positivity
  7. WHO consolidated guidelines on tuberculosis. Module 4: treatment and care
  8. Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis | New England Journal of Medicine
  9. Glial Fibrillary Acidic Protein Astrocytopathy: Review of Pathogenesis, Imaging Features, and Radiographic Mimics - PMC

Original Source(s)

Related Content